📰 NewsHub
🎯 728x90 Banner Ad - Replace with AdSense code
Premium ad placement for maximum visibility
NewsAPI
Jason Biggs Reportedly Called It Quits On His Marriage Over Lost ‘Spark’ After He ‘Shed A Lot Of Weight’ - Yahoo
Jason Biggs recently called it quits on his nearly two-decade marriage to Jenny Mollen, and now, sources claim that the The Jason Biggs Reportedly Cal...
NewsAPI
White picket fences were the American Dream. Now people want higher walls. - The Washington Post
A white picket fence in the front yard once signified middle-class neighborliness. But hardly anyone buys them anymore....
NewsAPI
Brazil identifies 2 possible Ebola patients, as WHO reports some recoveries in Congo - CBS News
The WHO said these five cases exemplify that recovery from the illness is possible, even without approved treatments or vaccines....
NewsAPI
The Winners, Losers From Arne Slot’s Liverpool Departure - Sports Illustrated
Regime change will prompt mixed emotions among the Liverpool squad....
NewsAPI
ASUS adds GeForce RTX 5080 TUF BTF with 16-pin and GC-HPWR power connectors - VideoCardz.com
ASUS TUF RTX 5080 BTF listed with 2730 MHz OC clock ASUS has added two new GeForce RTX 5080 BTF graphics cards to its TUF Gaming lineup. The new model...
NewsAPI
Undigested fructose linked to anxiety and brain inflammation - PsyPost
A new study finds that an inability to properly digest fructose alters the gut microbiome, triggering low-grade inflammation. This digestive disruptio...
NewsAPI
Scoring update: Mubadala New York Sail Grand Prix - SailGP
Racing from opening day of the Mubadala New York Sail Grand Prix will not count toward the event or 2026 Season standings, SailGP’s Race Committee h...
NewsAPI
DC insider: America faces more Trumps — or worse - Alternet
It’s impossible to understand American politics without also understanding the American economy (and vice versa). Politics and economics may be diff...
NewsAPI
A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China - CNBC
An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, according to data released...
NewsAPI
ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34% - Fierce Pharma
It’s the moment of truth for Akeso’s ivonescimab, and to many, a high-stakes test for China’s booming biotech industry. | Although the first-in-...
NewsAPI
Knicks NBA Finals Primer: San Antonio Spurs - Posting and Toasting
How do the Knicks stack up with their Finals opponents?...
NewsAPI
ASCO: Lilly exec points to ‘nutty’ 100% response rate for in vivo CAR-T as justifying Kelonia buyout - Fierce Biotech
Kelonia Therapeutics has shared the largest slice of data yet for its in vivo CAR-T, helping to justify the $3.2 billion price tag that Eli Lilly rece...
📱 320x250 Medium Rectangle Ad
Mobile-optimized advertisement